Virtus LifeSci Biotech Products ETF

BBP
$83.78 -1.52 (-1.78%)
Payout Frequency

Dividend History

Pay DateAmountEx-DateRecord Date
December 27, 2017$0.072017-12-202017-12-21
December 29, 2015$0.402015-12-212015-12-23

Dividends Summary

Company News

Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
Benzinga • Lekha Gupta • April 28, 2025

Merck & Co. has agreed to acquire SpringWorks Therapeutics for around $4 billion, a 26% premium over SpringWorks' 20-day average price. The acquisition will boost Merck's revenue and expand its U.S. healthcare presence, particularly in rare tumor treatments.

Gate Q1 2025 Transparency Report: Sustained Leadership in Crypto Markets with Multiple Metrics Hitting New Highs
GlobeNewswire Inc. • Gate.Io • April 10, 2025

Gate.io, a leading global digital asset platform, has released its Q1 2025 Transparency Report, showcasing impressive growth across multiple business segments, including trading volume, token performance, security, and product offerings.

4 Best-Performing Sector ETFs of June
Zacks Investment Research • Sweta Killa • July 1, 2024

We have highlighted four top-performing ETFs from different sectors that have led the way in June.

Biotech ETFs Stage Solid Comeback at the Start of 2024
Zacks Investment Research • Sweta Killa • January 9, 2024

The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.

5 Least-Hurt Biotech ETFs of the Last Week
Zacks Investment Research • Sanghamitra Saha • February 15, 2023

Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.

Related Companies